Opus Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $823K | Sell |
895
-181
| -17% | -$183K | 0.09% | 63 |
|
|
2025
Q4 | $1.16M | Sell |
1,076
-67
| -6% | -$64.1K | 0.13% | 53 |
|
|
2025
Q3 | $872K | Sell |
1,143
-36
| -3% | -$26.8K | 0.1% | 59 |
|
|
2025
Q2 | $919K | Hold |
1,179
| – | – | 0.11% | 56 |
|
|
2025
Q1 | $974K | Sell |
1,179
-1,735
| -60% | -$1.44M | 0.13% | 50 |
|
|
2024
Q4 | $2.25M | Sell |
2,914
-6,195
| -68% | -$5.13M | 0.29% | 37 |
|
|
2024
Q3 | $8.07M | Buy |
9,109
+8,006
| +726% | +$7.2M | 1.01% | 25 |
|
|
2024
Q2 | $999K | Sell |
1,103
-17
| -2% | -$13.6K | 0.14% | 53 |
|
|
2024
Q1 | $871K | Sell |
1,120
-159
| -12% | -$113K | 0.13% | 55 |
|
|
2023
Q4 | $746K | Sell |
1,279
-12
| -0.9% | -$7K | 0.12% | 58 |
|
|
2023
Q3 | $693K | Sell |
1,291
-125
| -9% | -$64.4K | 0.12% | 56 |
|
|
2023
Q2 | $664K | Buy |
1,416
+19
| +1% | +$7.97K | 0.11% | 61 |
|
|
2023
Q1 | $480K | Sell |
1,397
-24
| -2% | -$8.09K | 0.09% | 73 |
|
|
2022
Q4 | $520K | Sell |
1,421
-55
| -4% | -$19.5K | 0.1% | 70 |
|
|
2022
Q3 | $477K | Sell |
1,476
-10
| -0.7% | -$3.17K | 0.1% | 65 |
|
|
2022
Q2 | $482K | Sell |
1,486
-521
| -26% | -$156K | 0.1% | 70 |
|
|
2022
Q1 | $575K | Sell |
2,007
-3
| -0.1% | -$772 | 0.11% | 65 |
|
|
2021
Q4 | $555K | Buy |
2,010
+3
| +0.1% | +$761 | 0.11% | 63 |
|
|
2021
Q3 | $464K | Sell |
2,007
-750
| -27% | -$185K | 0.11% | 66 |
|
|
2021
Q2 | $633K | Sell |
2,757
-213
| -7% | -$42.8K | 0.14% | 60 |
|
|
2021
Q1 | $555K | Sell |
2,970
-567
| -16% | -$111K | 0.13% | 69 |
|
|
2020
Q4 | $597K | Hold |
3,537
| – | – | 0.15% | 70 |
|
|
2020
Q3 | $524K | Sell |
3,537
-565
| -14% | -$87.4K | 0.15% | 65 |
|
|
2020
Q2 | $673K | Sell |
4,102
-40
| -1% | -$6.14K | 0.21% | 59 |
|
|
2020
Q1 | $575K | Sell |
4,142
-339
| -8% | -$46.6K | 0.2% | 59 |
|
|
2019
Q4 | $589K | Buy |
4,481
+1,456
| +48% | +$169K | 0.17% | 64 |
|
|
2019
Q3 | $338K | Hold |
3,025
| – | – | 0.1% | 79 |
|
|
2019
Q2 | $335K | Sell |
3,025
-2,065
| -41% | -$243K | 0.1% | 94 |
|
|
2019
Q1 | $660K | Hold |
5,090
| – | – | 0.18% | 126 |
|
|
2018
Q4 | $590K | Buy |
+5,090
| New | +$569K | 0.12% | 131 |
|
|
2015
Q2 | – | Sell |
-7,155
| Closed | -$520K | – | 234 |
|
|
2015
Q1 | $520K | Hold |
7,155
| – | – | 0.08% | 157 |
|
|
2014
Q4 | $493K | Hold |
7,155
| – | – | 0.07% | 159 |
|
|
2014
Q3 | $464K | Sell |
7,155
-7,155
| -50% | -$453K | 0.06% | 169 |
|
|
2014
Q2 | $890K | Hold |
14,310
| – | – | 0.06% | 125 |
|
|
2014
Q1 | $842K | Hold |
14,310
| – | – | 0.06% | 121 |
|
|
2013
Q4 | $730K | Buy |
14,310
+7,160
| +100% | +$359K | 0.04% | 125 |
|
|
2013
Q3 | $360K | Hold |
7,150
| – | – | 0.02% | 125 |
|
|
2013
Q2 | $351K | Buy |
+7,150
| New | +$389K | 0.02% | 121 |
|
Other funds holding LLY
VCM
VPM
Opus Capital Group's LLY Position: Q1 2026 in Review
Opus Capital Group reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $183K and leaving 895 shares worth $823K. The position accounts for 0.09% of the portfolio, ranked #63.
Opus Capital Group first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $8.07M in Q3 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Opus Capital Group held 895 shares of Eli Lilly worth $823K as of Q1 2026.
- Opus Capital Group sold 181 Eli Lilly shares in Q1 2026, an estimated $183K.
- Eli Lilly made up 0.09% of Opus Capital Group's portfolio in Q1 2026, its #63 holding.
- Opus Capital Group first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Opus Capital Group's Eli Lilly position peaked at $8.07M in Q3 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Opus Capital Group's 13F filing for Q1 2026, filed 30 Apr 2026.